Search
Precision BioSciences Inc
DTILAdd to Watchlist
6.710USD
+0.150+2.29%
Close 10-21 16:00（ET）
173.12MMarket Cap
LossP/E TTM
Precision BioSciences Inc (DTIL) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Precision BioSciences Inc in the past month.
Strong Buy
3 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
29.400USD+409.53%
DTIL Analyst Recommendation Trends
In the current month, DTIL has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DTIL average Analyst price target in the last month is 29.400.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
5
4
4
4
4
DTIL Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Biontech SE
BNTX
4
12
8
0
0
24
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
5
16
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Financial Forecasting
Based on analysts' estimates, DTIL EPS is projected to reach -0.850 in FY2026Q3, following reported EPS of -1.263 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.54
-0.66
-0.79
-0.85
-0.83
Actual
1.05
-0.75
-1.26
--
--
Surprise
+296.82%
-14.29%
-59.85%
--
--
FAQs
What is Precision BioSciences Inc's expected revenue for the next quarter?
Precision BioSciences Inc's expected revenue is 1.10M.
What is Precision BioSciences Inc's price target?
Analysts forecast that Precision BioSciences Inc's price target is USD 29.40, with the highest forecast at USD 60.00 and the lowest forecast at USD 18.00.
How have Precision BioSciences IncDTIL's recent earnings per share performed?
The market expectation was USD -1.26, while Precision BioSciences IncDTIL's earnings per share (EPS) for the previous quarter was USD -0.75. EPS for the next quarter is expected at USD -0.85.
What is the analyst rating for Precision BioSciences Inc?
Based on the ratings of Precision BioSciences Inc's stock from 5 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.